Skip to Main content Skip to Navigation
Journal articles

Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance

Abstract : Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (TB) constitute a major public health concern. The objective was to determine the timing of pncA mutations that confer pyrazinamide (PZA) resistance in relation to mutations conferring resistance to isoniazid (INH) and rifampicin (RMP). For this goal, isolates from two major urban centres—Paris (101 strains) and Shanghai (171 strains)—were investigated for the association of pncA mutations with resistance to drugs other than PZA. The proportion of pncA mutations found in INH-monoresistant strains was not increased. In sum, pncA mutations associated with PZA resistance were found almost exclusively in MDR-TB strains, underlining the importance of determining PZA resistance when treating MDR- or XDR-TB.
Complete list of metadatas

Cited literature [60 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-01185256
Contributor : Amel Kevin Alame-Emane <>
Submitted on : Wednesday, August 19, 2015 - 4:05:03 PM
Last modification on : Thursday, August 27, 2020 - 3:12:20 PM
Long-term archiving on: : Friday, November 20, 2015 - 10:51:41 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Amel Kevin Alame-Emane, Peng Xu, C Pierre-Audigier, Véronique Cadet-Daniel, X Shen, et al.. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance. International Journal of Tuberculosis and Lung Disease, International Union Against Tuberculosis and Lung Disease, 2015, 19 (6), pp.679-84. ⟨10.5588/ijtld.14.0768⟩. ⟨pasteur-01185256⟩

Share

Metrics

Record views

256